The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer - Wikidata - wikimedia - TriplyDB

The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer

The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer

http://www.wikidata.org/entity/Q34053956

about

Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism Novel RNA markers in prostate cancer: functional considerations and clinical translation Long non-coding RNAs: potential new biomarkers for predicting tumor invasion and metastasis Long Non-coding RNAs in Urologic Malignancies: Functional Roles and Clinical Translation Expression of lncRNAs in Low-Grade Gliomas and Glioblastoma Multiforme: An In Silico Analysis.Biological Processes Discovered by High-Throughput Sequencing.The lncRNA DRAIC/PCAT29 Locus Constitutes a Tumor-Suppressive Nexus.Exploring functions of long noncoding RNAs across multiple cancers through co-expression network Long noncoding RNA PCAT-14 induces proliferation and invasion by hepatocellular carcinoma cells by inducing methylation of miR-372.A novel RNA in situ hybridization assay for the long noncoding RNA SChLAP1 predicts poor clinical outcome after radical prostatectomy in clinically localized prostate cancer.Multidrug-Resistance Related Long Non-Coding RNA Expression Profile Analysis of Gastric Cancer Long noncoding RNAs in cancer: from function to translation.Tonic suppression of PCAT29 by the IL-6 signaling pathway in prostate cancer: Reversal by resveratrol Long non-coding RNAs display higher natural expression variation than protein-coding genes in healthy humans High Expression of the Newly Found Long Noncoding RNA Z38 Promotes Cell Proliferation and Oncogenic Activity in Breast Cancer.Long noncoding RNAs in prostate cancer: overview and clinical implications.Analysis of long noncoding RNA expression in hepatocellular carcinoma of different viral etiology.The long non-coding RNA NKILA inhibits the invasion-metastasis cascade of malignant melanoma via the regulation of NF-ĸB.Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer Therapy.Identification of androgen-responsive lncRNAs as diagnostic and prognostic markers for prostate cancer Development of Peptidomimetic Inhibitors of the ERG Gene Fusion Product in Prostate Cancer.From junk to master regulators of invasion: lncRNA functions in migration, EMT and metastasis.A potential panel of four-long noncoding RNA signature in prostate cancer predicts biochemical recurrence-free survival and disease-free survival.PCA3 long noncoding RNA modulates the expression of key cancer-related genes in LNCaP prostate cancer cells.Deciphering the function of non-coding RNAs in prostate cancer.Novel long non-coding RNAs are specific diagnostic and prognostic markers for prostate cancer The bright side of dark matter: lncRNAs in cancer Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets.Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer The prognostic value of long noncoding RNAs in prostate cancer: a systematic review and meta-analysis.A long noncoding RNA signature for ulcerative colitis identifies IFNG-AS1 as an enhancer of inflammation.Long non-coding RNA Igf2as controls hepatocellular carcinoma progression through the ERK/MAPK signaling pathway.Long non-coding RNAs and prostate cancer.Long non-coding RNA GAS5 and ZFAS1 are prognostic markers involved in translation targeted by miR-940 in prostate cancer.The prognostic value of abnormally expressed lncRNAs in prostatic carcinoma: A systematic review and meta-analysis.Therapeutic Targeting of Long Non-Coding RNAs in Cancer.MechRNA: prediction of lncRNA mechanisms from RNA-RNA and RNA-protein interactions.The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications.The use of long non-coding RNAs as prognostic biomarkers and therapeutic targets in prostate cancer.Pathological bases and clinical impact of long noncoding RNAs in prostate cancer: a new budding star

P2860

Q26774456-3BAD89E7-72CE-492A-8C57-6CE2E453FD34 Q27021174-C53DE4A1-FDEC-4E39-ADA9-F76521835A57 Q28069105-6BEFA36E-EECB-491C-842C-79C892D89795 Q28071872-3089DFF2-B9AE-45DB-810A-ADF7740D726D Q30275293-69C0E584-552D-4D8A-BFC5-9F782EB2E778 Q30277646-C560EDE3-AE99-4084-A2E4-618522A6C819 Q30300669-2AFF8E8B-75F0-4D26-84A3-713BEE3AE665 Q33677918-8FB82074-58AC-4A8A-B557-446716442BE6 Q33798405-4F9534FB-A5B8-4F72-A0E5-1B44C8EBBDEA Q35022483-E8494B96-FE7C-48DA-9E82-926944C83265 Q35751343-6BD19942-CCF4-4366-86B1-20267869D553 Q36353705-BF7F357B-46E4-473F-9039-CE7834339818 Q36361936-7797B8B2-238E-495E-B60D-9A09E0996DBF Q36517502-31FE6C35-D4A5-4455-9769-1EA8A2589751 Q36764934-3549FA9B-CD7F-43C3-BA33-0018B5CEF384 Q37113177-44F80F4B-2AB6-402C-8809-6523094EB31B Q37444484-33C94188-10B3-4737-883E-2554BBCBF81F Q37596814-7782BD4C-6E5D-45E5-8984-050D3CDD637C Q37629548-09E6075B-33CE-41AF-B274-8B535A2F4D65 Q37645051-6A3FC556-7B5D-4FF8-A23E-846F361C5C00 Q38710470-30C8AF1F-580E-44D9-A03C-4FB2B2FFAD59 Q38732993-829F3223-9BFB-4AC2-9B6B-84E47AE7F0AD Q38758656-CBD96322-2F47-4106-8106-C52B888A8BAC Q38787568-05F897DC-CB52-4B27-AB56-0742489CFB9F Q38843392-F17418C2-C84F-4A40-A1E0-60B39352293B Q38909020-A2C57358-F5C0-4D94-A145-07A4350BA8BC Q38915010-F2B50C20-5F1B-4979-A816-5EA2AE554313 Q39031286-CBAFB0C6-3D43-479F-A281-97091F74CD8D Q39152842-6CAD564E-DAE8-4D8D-97A2-39FF91964E14 Q41339824-D93B1C94-E385-4AEA-A6A8-A58113F57892 Q41546047-08BE38F8-5695-4540-9B9B-BC96CD8F8E5B Q41611110-55CA3B0F-C2B6-436B-9D0C-057C0D59A3D9 Q43061701-65925E38-E7BF-40C6-907A-0B39671AF3B0 Q49213554-8F2A515E-029D-4616-B3B3-0D79166ADB5B Q49486523-0FCDB771-842F-4D40-8754-C880CCDF6F72 Q49961986-08A08197-B9A6-4AE5-94D6-7E94C29D06A3 Q52607047-D1FAF7DD-68D1-4FA4-BB9B-7C0903F455E6 Q53682879-D762F583-C49D-43DF-92BF-5EE6EC08FCE7 Q55356724-32E73E21-7E62-40BE-A6D4-F2263DCBBD87 Q57109348-9E476BBB-FD03-46C3-8EB1-A0D7A7593335

P2860

The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer

http://www.wikidata.org/entity/Q34053956

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer

@ast

The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer

@en

The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer

@nl

type

label

The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer

@ast

The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer

@en

The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer

@nl

prefLabel

The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer

@ast

The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer

@en

The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer

@nl

P1433

Q34053956-00B1E6E7-51D4-412A-A4AD-6820AD326791

P1476

Q34053956-4E30BA4C-ADCA-44D6-ADCE-1224B25DA3FF

P2093

Q34053956-075F4BAE-9259-44A9-91D5-570B55780E4D

Q34053956-1954C90B-A1E2-4618-997C-83008A9566C2

Q34053956-1AE51612-4318-489C-B6A7-DF290B34CDA1

Q34053956-26478FF0-3151-492F-A7C2-D6B9C6443970

Q34053956-27A8DF86-0139-493F-A626-8537A0168991

Q34053956-28C69023-60B4-4A98-A031-2D304BD75DF9

Q34053956-2A6B3C18-F32C-46B2-9C9D-D5642C812BD6

Q34053956-34A4486C-0BCD-4D3C-9892-587AB823456D

Q34053956-A2E5142A-CAF0-4629-B80D-8FE65A9C3C88

Q34053956-AAC72229-CAE9-419E-A443-7CBEE6856A14

P2860

Q34053956-15E94233-913C-45F7-B835-210FCC2DD822

Q34053956-248A2BEA-38E5-4F64-B510-DB6EDBD66B81

Q34053956-3BD3F64E-7A4D-49A3-A406-0FF7F5E7DB78

Q34053956-45CEB0CD-6E00-44D7-A72C-F04731566BD5

Q34053956-4BB99588-9874-4E8D-97DD-8F29B404B6AC

Q34053956-53720DBE-2074-466A-A408-E8BAA9DFB772

Q34053956-6E364979-BDB7-4586-8146-6C796232751F

Q34053956-73D9F9F8-ED73-428D-8C76-8C3B9F941FF0

Q34053956-75A2CB1F-A4A1-4B81-8974-1B2A40E25EEA

Q34053956-77E726F0-C9DD-4C7C-BA27-5AA57E2C599B

P304

Q34053956-C7F0E08C-66AF-49CA-9418-A4E44DE95775

P31

Q34053956-6A495303-1C9B-4ED8-BD03-0EC4F640E737

P356

Q34053956-5E316A3B-2F79-416B-9DDF-BE89B1F9BB3A

P433

Q34053956-E84E67F7-11EE-4EFB-80B7-86B60512E569

P478

Q34053956-8C624FD6-F204-4A67-B666-40AC850787AB

P50

Q34053956-4D0879CA-EE9F-40C6-B206-E286F3D36499

Q34053956-90B8C12F-0B05-4102-AB46-E1690D37C011

Q34053956-B195058F-037B-41AA-A947-8150BF17ABE4

Q34053956-D0B62C67-BCBB-49D3-ADA3-B7D118E7F20D

P577

Q34053956-4E4FA495-56D3-4AE4-93A8-7AEEACC82E66

P5875

Q34053956-588751B8-7FE1-499C-8A2B-CF8F7FF9B6B2

P698

Q34053956-282AA1EE-6CFC-43D1-96CB-F771DF4AE08D

P932

Q34053956-C36ED4C5-DBB5-4E3A-947C-AE9A44133B9A

P356

1541-7786.MCR-14-0257

P1433

Molecular Cancer Research

P1476

The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer

@en

P2093

Alexander Carley

http://www.w3.org/2001/XMLSchema#string

Anirban Sahu

http://www.w3.org/2001/XMLSchema#string

Arul M Chinnaiyan

http://www.w3.org/2001/XMLSchema#string

Dan R Robinson

http://www.w3.org/2001/XMLSchema#string

Felix Y Feng

http://www.w3.org/2001/XMLSchema#string

Matthew K Iyer

http://www.w3.org/2001/XMLSchema#string

Meilan Liu

http://www.w3.org/2001/XMLSchema#string

Rohit Malik

http://www.w3.org/2001/XMLSchema#string

Shruthi Subramaniyan

http://www.w3.org/2001/XMLSchema#string

Sumin Han

http://www.w3.org/2001/XMLSchema#string

P2860

Long noncoding RNA as modular scaffold of histone modification complexes

An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression

The emergence of lncRNAs in cancer biology

Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals

Landscape of transcription in human cells

Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells.

Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA.

CPC: assess the protein-coding potential of transcripts using sequence features and support vector machine.

Long non-coding RNAs: versatile master regulators of gene expression and crucial players in cancer.

Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer.

P304

1081-1087

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1541-7786.MCR-14-0257

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

John R. Prensner

Saravana M Dhanasekaran

P577

2014-07-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264010600

http://www.w3.org/2001/XMLSchema#string

P698

25030374

http://www.w3.org/2001/XMLSchema#string

P932

4135019

http://www.w3.org/2001/XMLSchema#string